Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000339021 | SCV000426840 | uncertain significance | Congenital hyperammonemia, type I | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000513937 | SCV000569051 | likely benign | not provided | 2018-04-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 18666241) |
Center for Pediatric Genomic Medicine, |
RCV000513937 | SCV000610055 | likely benign | not provided | 2017-04-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000513937 | SCV000697876 | benign | not provided | 2017-05-14 | criteria provided, single submitter | clinical testing | Variant summary: c.3141+15delA in CPS1 gene is an intronic change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this do not affect a normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.007693 (831/108016chrs tested), predominantly in individuals of European descent (0.01209; 715/ 59126 chrs tested), including two homozygous occurrences. The observed frequencies exceed the maximum expected allele frequency for a pathogenic variant of 0.0015%, suggesting that it is a benign polymorphism. The variant of interest has been reported as Benign by a reputable database/clinical laboratory. Taking together, based on the prevalence of this variant in general population the variant was classified as Benign. |
Labcorp Genetics |
RCV000339021 | SCV001732366 | benign | Congenital hyperammonemia, type I | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000513937 | SCV004011292 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | CPS1: BS2 |
Natera, |
RCV000339021 | SCV002076256 | benign | Congenital hyperammonemia, type I | 2019-09-27 | no assertion criteria provided | clinical testing |